Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GILD

GILEAD SCIENCES, INC.

CIK 0000882095 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$146.12
↑ 2.68 (1.87%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals

Key stats

Market Cap
$181.18B
P/E Ratio
-55.92
EPS
6.84
Dividend Yield
2.2%
52W Position
77%
Beta
0.31

Valuation multiples

Fwd P/E
15.22
PEG
2.14
P/B
15.43
P/S
5.95
EV/Revenue
6.81
ROE
-27.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 77%
$108.46$157.29

Latest Financials

2025-12-31 FY
Revenue
$29.44B
Net Income
$8.51B
Total Assets
$59.02B
Free Cash Flow
$9.46B

Recent news